COVID-19 Testing, Treatment and Visitation Guidance

• IHCA Clinical Guidance Summary – Revised 5/8/23
• ICAL Assisted Living Outbreak Checklist (PDF) – updated 7/12/21

• CDC Updated Guidance on Antigen Testing in Long-Term Care Facilities
• CDC Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 – updated 12/29/20
• CDC Interim Guidance for Antigen Testing for SARS-CoV-2 – updated 12/16/20
• CDC Information on use of COVID-19 Antigen Tests in LTC

• QSO-20-38-NH  Testing Requirements -Revised 9/23/2022
• AHCA’s Guidance Related to Updated CDC and CMS Requirements – 9/29/22
• CMS Testing FAQ’s & CLIA Guidance During the COVID-19 Emergency
• CMS Laboratory Data Reporting For COVID-19 Testing FAQs
• Medicare Coverage of COVID-19 Testing

• FDA Information on COVID-19 Tests

• IDPH Monthly HAI Call Schedule and Login Information – 8/30/21
• IDPH: LTC Antigen Testing Guidance – 5-6-21

• Patient Log with controls BinaxNOW Example Sheet
• Patient Log with controls BinaxNOW_
• Training Assessment Sheet CoVID-19 Abbott BinaxNOW
• Certification of Training CoVID-19 Abbott BinaxNOW
• COVID-19 Procedure Abbott BinaxNOW
• COVID-19-Home-Care-Hospice-Checklist

Skilled Nursing Facilities Resources

• IHCA Clinical Guidance Summary – Revised 5/8/23
• QSO-20-39-NH  Visitation during COVID-19 – Revised 9/23/2022
• AHCA’s Guidance Related to Updated CDC and CMS Requirements – 9/29/22

Assisted Living and Residential Care Facility Program Resources

• ICAL Clinical Guidance Summary – Updated 6/13/22
• ICAL Assisted Living Outbreak Checklist (PDF) – updated 7/12/21

• HHS Therapeutic Definition – 2/1/21
• FDA Bamlanivimab Letter of Authorization (EUA) – 11/10/20
• FDA Bamlanivimab Provider Fact Sheet – 1/28/21
• FDA Casirivimab/imdevimab Letter of Authorization (EUA) – 11/21/20
• FDA Casirivimab/imdevimab Provider Fact Sheet – 12/2020
• IDPH COVID-19 Monoclonal Antibody Provider Request Form – 2/1/21
• IDPH COVID-19 Monoclonal Antibody Therapeutics Information for Providers – 2/1/21